Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
The Journal of the Arkansas Medical Society
|
July 1, 1988
Adenocarcinoma of lung and sigmoid colon
J R Phillips, W E Atkinson, H A Farley, et al.
The International Journal of Medical Robotics + Computer Assisted Surgery : MRCAS
|
July 24, 2015
Robotic pancreaticoduodenectomy: comparison of complications and cost to the open approach
E H Baker, S W Ross, R Seshadri, et al.
Cancer
|
September 26, 1997
Teniposide (VM-26) as a single drug treatment for patients with extensive small cell lung carcinoma: a Phase II study of the Southwest Oncology Group
P N Grozea, J J Crowley, V A Canfield, et al.
The American Surgeon
|
July 4, 2025
Does the 1:1:1 Transfusion Ratio Mortality Benefit Hold True in Ultra-massive Transfusion? A Study From the Product (Patient Related Outcomes During Ultra-massive transfusion multi-Center Trial) Consortium
C H Meyer, Z Grady, R N Smith, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
The Journal of the Arkansas Medical Society
|
July 1, 1988
Adenocarcinoma of lung and sigmoid colon
J R Phillips, W E Atkinson, H A Farley, et al.
The International Journal of Medical Robotics + Computer Assisted Surgery : MRCAS
|
July 24, 2015
Robotic pancreaticoduodenectomy: comparison of complications and cost to the open approach
E H Baker, S W Ross, R Seshadri, et al.
Cancer
|
September 26, 1997
Teniposide (VM-26) as a single drug treatment for patients with extensive small cell lung carcinoma: a Phase II study of the Southwest Oncology Group
P N Grozea, J J Crowley, V A Canfield, et al.
The American Surgeon
|
July 4, 2025
Does the 1:1:1 Transfusion Ratio Mortality Benefit Hold True in Ultra-massive Transfusion? A Study From the Product (Patient Related Outcomes During Ultra-massive transfusion multi-Center Trial) Consortium
C H Meyer, Z Grady, R N Smith, et al.
Page
of 2